Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

December 31, 2007

Conditions

Leishmaniasis

Interventions

DRUG

miltefosine: 2.5 mg/kg/day for 42 days

Trial Locations (1)

Palos Blancos, Palos Blancos

All Listed Sponsors

lead

AB Foundation

OTHER

NCT00373568 - Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis | Biotech Hunter | Biotech Hunter